API Gallery
The global Picloxydine Dihydrochloride API market is projected to grow at a CAGR of 5.4% during the forecast period, driven by its increasing application in ophthalmic formulations and antimicrobial treatments.
The Grape Seed Extract market is projected to grow at a CAGR of 6.4% between 2025 and 2035. This growth is driven by the increasing demand for antioxidant-rich ingredients in nutraceuticals and cosmetics, and the rising popularity of plant-based APIs in preventive healthcare.
The global Pidotimod API market is projected to grow at a CAGR of 6.1% during the forecast period, driven by its increasing use as an immunostimulant in the treatment of recurrent respiratory tract infections, particularly in pediatric and elderly populations.
The Grapiprant market is projected to grow at a CAGR of 5.9% between 2025 and 2035. The growth is driven by increasing demand for targeted anti-inflammatory treatments in veterinary medicine, particularly for managing osteoarthritis in dogs.
The global Pilocarpine Hydrochloride market is projected to grow at a CAGR of 5.7% during the forecast period, driven by its expanding application in ophthalmology and neurology.
The Grazoprevir market is projected to grow at a CAGR of 7.2% during the forecast period 2025 -2035. This growth is primarily driven by increasing demand for effective treatments for chronic hepatitis C (HCV) infection, growing global awareness of HCV, and a focus on enhancing the efficacy and safety of antiviral therapies. Grazoprevir’s role in combination therapies, particularly with NS5A inhibitors, boosts its adoption in the pharmaceutical industry for HCV treatment.
The global Pilocarpine Nitrate market is projected to grow at a CAGR of 5.2% during the forecast period, driven by its expanding role in ophthalmic care, particularly for glaucoma management and ocular hypertension. Known for its ability to induce miosis and lower intraocular pressure, Pilocarpine Nitrate remains a key therapeutic agent in eye surgery preparation and chronic eye condition treatment
The Glycerine market is projected to grow at a CAGR of 5.9% between 2025 and 2035, driven by increasing demand for pharmaceutical formulations and expanding applications in the food and beverage industries. The rise in consumer preference for natural ingredients in cosmetics and personal care products further supports this growth.
The global Pimavanserin Tartrate market is projected to grow at a CAGR of 6.6% during the forecast period, driven by its rising use in treating Parkinson’s disease psychosis and its emerging role in managing neuropsychiatric disorders such as schizophrenia and dementia-related hallucinations.
The global Pimavanserin market is projected to grow at a CAGR of 7.3% during the forecast period, driven by its expanding application in the treatment of Hepatitis C Virus (HCV) across genotypes 1–6.
The global Pimecrolimus market is projected to grow at a CAGR of 5.9% during the forecast period, driven by its expanding application in the treatment of atopic dermatitis and other inflammatory skin disorders.
The global Pimobendan market is projected to grow at a CAGR of 6.3% during the forecast period, driven by its expanding application in veterinary cardiology, particularly in the treatment of canine congestive heart failure (CHF).
The Green Coffee Extract API market is projected to grow at a CAGR of 7.9% from 2025 to 2035. This growth is primarily driven by the increasing global prevalence of obesity and type 2 diabetes, growing consumer demand for weight management and metabolic health supplements, and the rising popularity of natural, plant-based ingredients in the nutraceutical and dietary supplement industries.
The global Pimozide market is projected to grow at a CAGR of 4.8% during the forecast period, driven by its continued application in the treatment of chronic psychotic disorders, particularly Tourette syndrome and schizophrenia.
The global Pinaverium Bromide market is projected to grow at a CAGR of 5.4% during the forecast period, driven by its increasing use in the treatment of irritable bowel syndrome (IBS) and gastrointestinal (GI) motility disorders.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
